BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1772293)

  • 1. Determination of oxygen radical production in spondyloarthropathies by whole blood chemiluminescence.
    Ristola M; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1991 Nov; 50(11):782-6. PubMed ID: 1772293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased oxygen radical production determined by whole blood chemiluminescence in patients with previous Yersinia arthritis.
    Ristola M
    APMIS; 1990 Feb; 98(2):125-30. PubMed ID: 2302347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen radical production and trapping in subjects with previous Yersinia infection.
    Ristola M; Metsä-Ketelä T; Leirisalo-Repo M; Repo H
    Inflammation; 1992 Jun; 16(3):273-83. PubMed ID: 1323531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphonuclear leucocyte function and previous yersinia arthritis: enhanced chemokinetic migration and oxygen radical production correlate with the severity of the acute disease.
    Koivuranta-Vaara P; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1987 Apr; 46(4):307-13. PubMed ID: 3592787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The phagocyte oxidative metabolism function in ankylosing spondylitis.
    Wendling D; Didier JM; Vuitton DA
    Rheumatol Int; 1991; 11(4-5):187-9. PubMed ID: 1664542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole blood luminol-enhanced chemiluminescence: statistical analysis of the responses of different subjects.
    Ristola M; Repo H
    J Biolumin Chemilumin; 1990; 5(3):155-60. PubMed ID: 2220413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oxidative metabolism of circulating phagocytes in ankylosing spondylitis: determination by whole blood chemiluminescence.
    Ho KJ; Chen PQ; Chang CY; Lu FJ
    Ann Rheum Dis; 2000 May; 59(5):338-41. PubMed ID: 10784514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphonuclear leucocyte function and previous yersinia arthritis: correlation of enhanced superoxide production with late manifestations.
    Repo H; Koivuranta-Vaara P; Leirisalo-Repo M
    Ann Rheum Dis; 1988 Jun; 47(6):452-7. PubMed ID: 2838004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced inflammatory reactivity in the pathogenesis of spondyloarthropathies.
    Repo H; Ristola M; Leirisalo-Repo M
    Autoimmunity; 1990; 7(4):245-54. PubMed ID: 2102768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil functions, spondylarthropathies and HLA-B27: a study of 43 patients.
    Biasi D; Carletto A; Caramaschi P; Bellavite P; Andrioli G; Caraffi M; Pacor ML; Bambara LM
    Clin Exp Rheumatol; 1995; 13(5):623-7. PubMed ID: 8575141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil function and HLA-B27. Superoxide production and yersinicidal activity of neutrophils from patients with previous yersinia arthritis.
    Repo H; Leirisalo-Repo M; Skurnik M; Tiilikainen A
    Med Biol; 1984; 62(2):91-4. PubMed ID: 6088912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM, IgG, and IgA synthesis in vitro in persons suffering from yersinia arthritis and in patients with ankylosing spondylitis.
    Vuento R; Eskola J; Leino R; Koskimies S; Viander M
    Ann Rheum Dis; 1984 Apr; 43(2):186-91. PubMed ID: 6370149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced neutrophil migration in vivo HLA B27 positive subjects.
    Koivuranta-Vaara P; Repo H; Leirisalo M; Kiistala U; Osterman T; Vapaatalo H
    Ann Rheum Dis; 1984 Apr; 43(2):181-5. PubMed ID: 6370148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Reactive Yersinia pseudotuberculosis arthritis with acute hepatic histological involvement disclosing latent ankylosing spondylitis].
    Doury P; Pattin S; Eulry F; Bernard J; Masson C
    Rev Rhum Mal Osteoartic; 1983 Dec; 50(12):821-3. PubMed ID: 6607507
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of tetracaine and bupivacaine on chemiluminescence generated by formyl-methionyl-leucyl-phenylalanine-stimulated human leukocytes and cell-free systems.
    Günaydin B; Demiryürek AT
    Int Immunopharmacol; 2003 May; 3(5):757-64. PubMed ID: 12757744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of lymphotoxic antibodies in patients with Yersinia-induced arthritis, Reiter's syndrome and ankylosing spondylitis.
    Kono DH; Park MS; Yu DT; Granfors K; Toivanen A
    Clin Exp Rheumatol; 1984; 2(4):303-7. PubMed ID: 6335862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal permeability in patients with yersinia triggered reactive arthritis.
    Lahesmaa-Rantala R; Magnusson KE; Granfors K; Leino R; Sundqvist T; Toivanen A
    Ann Rheum Dis; 1991 Feb; 50(2):91-4. PubMed ID: 1998397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luminol-enhanced chemiluminescence of whole blood. Statistical analysis, and comparison of the responses of different subjects.
    Ristola M; Repo H
    APMIS; 1989 Jun; 97(6):503-12. PubMed ID: 2736103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release of oxygen radicals by articular chondrocytes: a study of luminol-dependent chemiluminescence and hydrogen peroxide secretion.
    Rathakrishnan C; Tiku K; Raghavan A; Tiku ML
    J Bone Miner Res; 1992 Oct; 7(10):1139-48. PubMed ID: 1280902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Yersinia enterocolitica, ankylosing spondylitis and HL-A B27].
    Kluin-Nelemans JC; Meuwissen OJ
    Ned Tijdschr Geneeskd; 1977 Apr; 121(15):629-31. PubMed ID: 854105
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.